Search research articles
Contact Us
Filters
Showing results (21-30 of 26) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 26 results.
JCI Insight
|
April 5, 2019
Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy
Lillian Sun, Paul E Clavijo, Yvette Robbins, et al.
Cell Reports
|
October 2, 2012
FUS-SMN protein interactions link the motor neuron diseases ALS and SMA
Tomohiro Yamazaki, Shi Chen, Yong Yu, et al.
Cancer Cell
|
April 16, 2015
AXL mediates resistance to PI3Kα inhibition by activating the EGFR/PKC/mTOR axis in head and neck and esophageal squamous cell carcinomas
Moshe Elkabets, Evangelos Pazarentzos, Dejan Juric, et al.
Cancer Research
|
August 10, 2013
An antibody that locks HER3 in the inactive conformation inhibits tumor growth driven by HER2 or neuregulin
Andrew P Garner, Carl U Bialucha, Elizabeth R Sprague, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 7, 2019
Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer
Anthony D Saleh, Hui Cheng, Scott E Martin, et al.
Science Translational Medicine
|
May 26, 2017
The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation
David P Kodack, Vasileios Askoxylakis, Gino B Ferraro, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 26) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 26 results.
JCI Insight
|
April 5, 2019
Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy
Lillian Sun, Paul E Clavijo, Yvette Robbins, et al.
Cell Reports
|
October 2, 2012
FUS-SMN protein interactions link the motor neuron diseases ALS and SMA
Tomohiro Yamazaki, Shi Chen, Yong Yu, et al.
Cancer Cell
|
April 16, 2015
AXL mediates resistance to PI3Kα inhibition by activating the EGFR/PKC/mTOR axis in head and neck and esophageal squamous cell carcinomas
Moshe Elkabets, Evangelos Pazarentzos, Dejan Juric, et al.
Cancer Research
|
August 10, 2013
An antibody that locks HER3 in the inactive conformation inhibits tumor growth driven by HER2 or neuregulin
Andrew P Garner, Carl U Bialucha, Elizabeth R Sprague, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 7, 2019
Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer
Anthony D Saleh, Hui Cheng, Scott E Martin, et al.
Science Translational Medicine
|
May 26, 2017
The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation
David P Kodack, Vasileios Askoxylakis, Gino B Ferraro, et al.
Page
of 3